BCAX
Price
$17.86
Change
+$0.55 (+3.18%)
Updated
Oct 15, 11:15 AM (EDT)
Capitalization
945.34M
33 days until earnings call
Intraday Buy/Sell Signals
VTYX
Price
$3.75
Change
+$0.11 (+3.01%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
260.63M
26 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BCAX vs VTYX

Header iconBCAX vs VTYX Comparison
Open Charts BCAX vs VTYXBanner chart's image
Bicara Therapeutics
Price$17.86
Change+$0.55 (+3.18%)
Volume$2K
Capitalization945.34M
Ventyx Biosciences
Price$3.75
Change+$0.11 (+3.01%)
Volume$350
Capitalization260.63M
BCAX vs VTYX Comparison Chart in %
BCAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAX vs. VTYX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (BCAX: $17.31 vs. VTYX: $3.65)
Brand notoriety: BCAX and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 194% vs. VTYX: 54%
Market capitalization -- BCAX: $945.34M vs. VTYX: $260.63M
BCAX [@Biotechnology] is valued at $945.34M. VTYX’s [@Biotechnology] market capitalization is $260.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCAX and VTYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 6 TA indicator(s) are bullish while VTYX’s TA Score has 6 bullish TA indicator(s).

  • BCAX’s TA Score: 6 bullish, 4 bearish.
  • VTYX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BCAX and VTYX are a good buy in the short-term.

Price Growth

BCAX (@Biotechnology) experienced а -4.73% price change this week, while VTYX (@Biotechnology) price change was -8.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

BCAX is expected to report earnings on Nov 18, 2025.

VTYX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCAX($945M) has a higher market cap than VTYX($261M). VTYX YTD gains are higher at: 66.895 vs. BCAX (-0.631). BCAX has higher annual earnings (EBITDA): -121M vs. VTYX (-129.1M). BCAX has more cash in the bank: 437M vs. VTYX (209M). BCAX has less debt than VTYX: BCAX (2.24M) vs VTYX (10.3M). BCAX (0) and VTYX (0) have equivalent revenues.
BCAXVTYXBCAX / VTYX
Capitalization945M261M362%
EBITDA-121M-129.1M94%
Gain YTD-0.63166.895-1%
P/E RatioN/AN/A-
Revenue00-
Total Cash437M209M209%
Total Debt2.24M10.3M22%
TECHNICAL ANALYSIS
Technical Analysis
BCAXVTYX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 22 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCNWF0.080.01
+14.43%
Hypercharge Networks Corp.
IMBBF42.001.30
+3.19%
Imperial Brands PLC
ALGGF0.12N/A
N/A
Alliance Global Group, Inc.
KOBNF29.57N/A
N/A
Kobe Bussan Co., Ltd.
SYZLF3.94-0.12
-2.88%
Sylogist Ltd.

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with SYRE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-6.48%
SYRE - BCAX
43%
Loosely correlated
+11.02%
IMNM - BCAX
41%
Loosely correlated
-1.26%
VTYX - BCAX
40%
Loosely correlated
-1.48%
XENE - BCAX
39%
Loosely correlated
+1.45%
ORKA - BCAX
39%
Loosely correlated
+7.78%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-1.48%
KYMR - VTYX
47%
Loosely correlated
-2.87%
ADCT - VTYX
44%
Loosely correlated
-10.85%
SYRE - VTYX
44%
Loosely correlated
+11.02%
ARWR - VTYX
43%
Loosely correlated
-0.80%
LXEO - VTYX
43%
Loosely correlated
+3.66%
More